Literature DB >> 32440986

Myocardin-Related Transcription Factor A Mediates LPS-Induced iNOS Transactivation.

Lin Lin1, Qiumei Zhang1, Hongwei Fan1, Hongwei Zhao1, Yuyu Yang2.   

Abstract

Macrophage-dependent inflammation plays a critical role in atherogenesis. Inducible nitric oxide synthase (iNOS) is one of key pro-inflammatory mediators produced in macrophages and its levels can be upregulated by lipopolysaccharide (LPS). The epigenetic mechanism whereby LPS induces iNOS transcription is incompletely understood. We show here myocardin-related transcription factor A (MRTF-A) potentiated iNOS promoter activity in macrophages. There was a decrease in LPS-induced iNOS expression in several cell models due to the lack of MRTF-A. LPS treatment promoted nuclear accumulation of MRTF-A and its interaction with NF-κB/p65 on the iNOS promoter. The absence of MRTF-A prevented the accumulation of active histone marks on the iNOS promoter in response to LPS treatment. Mechanistically, MRTF-A recruited ASH2, a key component of the mammalian histone H3K4 methyltransferase complex, to the iNOS promoter. Silencing of ASH2 attenuated iNOS expression following LPS treatment. Together, our data highlight a role for MRTF-A-dependent recruitment of H3K4 methyltransferase in iNOS induction and as such provide a novel target in the intervention of atherosclerosis.

Entities:  

Keywords:  ASH2; Atherosclerosis; Epigenetics; MRTF-A; Macrophage; Transcriptional regulation

Mesh:

Substances:

Year:  2020        PMID: 32440986     DOI: 10.1007/s10753-020-01213-0

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.657


  39 in total

1.  Induction of inducible nitric oxide synthase (iNOS) expression by oxLDL inhibits macrophage derived foam cell migration.

Authors:  H Huang; P Koelle; M Fendler; A Schröttle; M Czihal; U Hoffmann; M Conrad; P J Kuhlencordt
Journal:  Atherosclerosis       Date:  2014-05-10       Impact factor: 5.162

2.  Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation.

Authors:  Kristina Edfeldt; Jesper Swedenborg; Göran K Hansson; Zhong-qun Yan
Journal:  Circulation       Date:  2002-03-12       Impact factor: 29.690

3.  Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL.

Authors:  X H Xu; P K Shah; E Faure; O Equils; L Thomas; M C Fishbein; D Luthringer; X P Xu; T B Rajavashisth; J Yano; S Kaul; M Arditi
Journal:  Circulation       Date:  2001-12-18       Impact factor: 29.690

4.  Genetic deficiency of inducible nitric oxide synthase reduces atherosclerosis and lowers plasma lipid peroxides in apolipoprotein E-knockout mice.

Authors:  P J Kuhlencordt; J Chen; F Han; J Astern; P L Huang
Journal:  Circulation       Date:  2001-06-26       Impact factor: 29.690

5.  Effect of chronic treatment with the inducible nitric oxide synthase inhibitor N-iminoethyl-L-lysine or with L-arginine on progression of coronary and aortic atherosclerosis in hypercholesterolemic rabbits.

Authors:  D Behr-Roussel; A Rupin; S Simonet; E Bonhomme; S Coumailleau; A Cordi; B Serkiz; J N Fabiani; T J Verbeuren
Journal:  Circulation       Date:  2000-08-29       Impact factor: 29.690

Review 6.  Hierarchies of NF-κB target-gene regulation.

Authors:  Stephen T Smale
Journal:  Nat Immunol       Date:  2011-07-19       Impact factor: 25.606

Review 7.  The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models.

Authors:  Christian Weber; Alma Zernecke; Peter Libby
Journal:  Nat Rev Immunol       Date:  2008-10       Impact factor: 53.106

8.  Enhanced expression of inducible nitric oxide synthase in murine macrophages and glomerular mesangial cells by elevated glucose levels: possible mediation via protein kinase C.

Authors:  K Sharma; T M Danoff; A DePiero; F N Ziyadeh
Journal:  Biochem Biophys Res Commun       Date:  1995-02-06       Impact factor: 3.575

9.  The cytokine responsive vascular smooth muscle cell enhancer of inducible nitric oxide synthase. Activation by nuclear factor-kappa B.

Authors:  J Spink; J Cohen; T J Evans
Journal:  J Biol Chem       Date:  1995-12-08       Impact factor: 5.157

10.  Monocyte/macrophage suppression in CD11b diphtheria toxin receptor transgenic mice differentially affects atherogenesis and established plaques.

Authors:  Victoria Stoneman; Denise Braganza; Nichola Figg; John Mercer; Richard Lang; Martin Goddard; Martin Bennett
Journal:  Circ Res       Date:  2007-02-22       Impact factor: 17.367

View more
  3 in total

Review 1.  A Probable Way Vitamin D Affects Autism Spectrum Disorder: The Nitric Oxide Signaling Pathway.

Authors:  Bing Wang; HanYu Dong; HongHua Li; XiaoJing Yue; Lin Xie
Journal:  Front Psychiatry       Date:  2022-05-26       Impact factor: 5.435

2.  AXL Inhibits Proinflammatory Factors to Relieve Rheumatoid Arthritis Pain by Regulating the TLR4/NF-κB Signaling Pathway.

Authors:  Guangzan Zhou; Hang Li
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-09       Impact factor: 2.650

Review 3.  MRTF: Basic Biology and Role in Kidney Disease.

Authors:  Maria Zena Miranda; Zsuzsanna Lichner; Katalin Szászi; András Kapus
Journal:  Int J Mol Sci       Date:  2021-06-03       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.